These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2047070)

  • 21. The prognostic significance of peritoneal cytology for stage I endometrial cancer.
    Turner DA; Gershenson DM; Atkinson N; Sneige N; Wharton AT
    Obstet Gynecol; 1989 Nov; 74(5):775-80. PubMed ID: 2812655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of primary adenocarcinoma of the uterine cervix.
    Chen RJ; Chang DY; Yen ML; Lee EF; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1998 May; 69(2):157-64. PubMed ID: 9600824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early adenocarcinoma of the uterine cervix.
    Kaku T; Kamura T; Sakai K; Amada S; Kobayashi H; Shigematsu T; Saito T; Nakano H
    Gynecol Oncol; 1997 May; 65(2):281-5. PubMed ID: 9159338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
    Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
    Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of FIGO Stage IIIc endometrial cancer patients.
    McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
    Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival.
    Berek JS; Hacker NF; Fu YS; Sokale JR; Leuchter RC; Lagasse LD
    Obstet Gynecol; 1985 Jan; 65(1):46-52. PubMed ID: 3966022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma.
    Doering DL; Barnhill DR; Weiser EB; Burke TW; Woodward JE; Park RC
    Obstet Gynecol; 1989 Dec; 74(6):930-3. PubMed ID: 2586959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix.
    Kaspar HG; Dinh TV; Doherty MG; Hannigan EV; Kumar D
    Obstet Gynecol; 1993 Feb; 81(2):296-300. PubMed ID: 8423968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.
    Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA
    Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
    Larson DM; Johnson KK; Reyes CN; Broste SK
    Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
    Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
    Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Influence of histologic type on prognosis of patients undergoing curative intervention for gastric adenocarcinoma. Italian multicenter study].
    de Manzoni G; Roviello F; Marrelli D; Morgagni P; Di Leo A; Saragoni L; De Stefano A; Bazzocchi F; Pinto E
    Ann Ital Chir; 2001; 72(1):13-8. PubMed ID: 11464489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors of adenocarcinoma of the uterine cervix.
    Ishikawa H; Nakanishi T; Inoue T; Kuzuya K
    Gynecol Oncol; 1999 Apr; 73(1):42-6. PubMed ID: 10094878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.